Synthego snaps up $41 mln Series B
Silicon Valley-based Synthego, a provider of genome engineering solutions, has raised $41 million in Series B financing. 8VC led the round with participation from other investors that included AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equities, ZhenFund, Founders Fund, Menlo Ventures, WI Harper Group and SciFi VC.
4 January 2017•1 min read
